Biotech News

atai Life Sciences Acquires Psilera’s DMT Patent Portfolio

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Anthos Therapeutics to Be Acquired by Novartis

AdvanCell Expands Strategic Collaboration with Eli Lilly for Targeted Alpha Therapies

Alterity Therapeutics Secures A$40M to Advance Neurodegenerative Drug Development

Hoth Therapeutics Partners with OnTargetx to Advance Cancer Therapy HT-KIT

Alumis and ACELYRIN Join Forces to Drive Late-Stage Immunology Therapies

Immuneering and Regeneron Partner to Evaluate IMM-1-104 in RAS-Mutant Lung Cancer

Belite Bio Secures $15 Million in Direct Offering with Healthcare Investor

Aplagon Secures €7M to Advance Phase 2a Trial for Thrombo-Inflammatory Drug APAC

Akribion Therapeutics Raises €8M to Advance RNA-Guided Cell Depletion Technology

BioNTech Completes Acquisition of Biotheus

AdvanCell Secures $112M Series C to Expand Radionuclide Cancer Therapies

Enduro Genetics Lands €12M Investment to Expand Bioproduction Technology

Vanda and AnaptysBio Finalise Exclusive Licence Agreement for Imsidolimab in Rare Skin Disease

Tensegrity Pharma Secures JPY150 million (USD0.97 Million) in Seed Funding to Advance Cachexia Drug

Valneva SE Signs $32.8 Million Deal to Supply IXIARO to U.S. Military